Effects and duration of exercise-based prehabilitation in surgical therapy of colon and rectal cancer: a systematic review and meta-analysis.

6-min walk distance (6MWD) Colorectal carcinoma (CRC) Length of stay (LOS) Morbidity and mortality Postoperative outcome Preoperative physical exercise

Journal

Journal of cancer research and clinical oncology
ISSN: 1432-1335
Titre abrégé: J Cancer Res Clin Oncol
Pays: Germany
ID NLM: 7902060

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 24 03 2022
accepted: 23 05 2022
pubmed: 14 6 2022
medline: 6 8 2022
entrez: 13 6 2022
Statut: ppublish

Résumé

Functional capacity is an independent indicator of morbidity in colon and rectal cancer surgery. This systematic review describes the evaluated and synthesized effects of exercise prehabilitation depending on the duration of interventions on functional and postoperative outcomes in colon and rectal cancer surgery. Three electronic databases (MEDLINE Pubmed, Web of Sciences, and Cochrane Registry) were systematically searched (January 2022) for controlled trials that investigated the effects of prehabilitation prior to colo-rectal cancer resection. Twenty-three studies were included in this systematic review and 14 in our meta-analyses assessing these outcomes: the 6 min walk distance (6MWD), postoperative overall complications, and length of stay (LOS). We observed a significant improvement in preoperative functional capacity as measured with 6MWD (mean difference: 30.8 m; 95% CI 13.3, 48.3; p = 0.0005) due to prehabilitation. No reductions in LOS (mean difference: - 0.27 days; 95% CI - 0.93, 0.40; p = 0.5) or postoperative overall complications (Odds ratio: 0.84; 95% CI 0.53, 1.31; p = 0.44) were observed. Prehabilitation lasting more than 3 weeks tended to lower overall complications (Odds ratio: 0.66; 95% CI 0.4, 1.1; p = 0.11). However, the prehabilitation time periods differed between colon and rectal carcinoma resections. Prehabilitation while the patient is preparing to undergo surgery for colorectal carcinoma improves functional capacity; and might reduce postoperative overall complications, but does not shorten the LOS. The studies we reviewed differ in target variables, design, and the intervention's time period. Multicenter studies with sufficient statistical power and differentiating between colon and rectal carcinoma are needed to develop implementation strategies in the health care system. PROSPERO CRD42022310532.

Identifiants

pubmed: 35695931
doi: 10.1007/s00432-022-04088-w
pii: 10.1007/s00432-022-04088-w
pmc: PMC9349170
doi:

Types de publication

Journal Article Meta-Analysis Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2187-2213

Informations de copyright

© 2022. The Author(s).

Références

Ann Surg. 2013 Jun;257(6):999-1004
pubmed: 23665968
BMC Med Res Methodol. 2014 Dec 19;14:135
pubmed: 25524443
Surg Endosc. 2013 Apr;27(4):1072-82
pubmed: 23052535
Am J Phys Med Rehabil. 2013 Aug;92(8):715-27
pubmed: 23756434
Colorectal Dis. 2016 Jan;18(1):O43-50
pubmed: 26500155
Eur J Anaesthesiol. 2020 Nov;37(11):969-978
pubmed: 32976204
Colorectal Dis. 2019 May;21(5):548-562
pubmed: 30657249
Acta Oncol. 2018 Jun;57(6):849-859
pubmed: 29327644
Acta Physiol (Oxf). 2017 Jun;220(2):218-228
pubmed: 27888580
Int J Colorectal Dis. 2018 Jul;33(7):979-983
pubmed: 29574506
Ann Surg. 2022 Feb 1;275(2):e299-e306
pubmed: 33443905
Res Synth Methods. 2020 Sep;11(5):641-654
pubmed: 32562361
Ann Surg. 2018 Jan;267(1):50-56
pubmed: 28489682
Eur J Surg Oncol. 2016 Sep;42(9):1322-30
pubmed: 27156145
Integr Cancer Ther. 2018 Sep;17(3):952-959
pubmed: 29888608
CA Cancer J Clin. 2012 Jul-Aug;62(4):243-74
pubmed: 22539238
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Tohoku J Exp Med. 2009 Feb;217(2):109-15
pubmed: 19212103
World J Surg. 2019 Jul;43(7):1661-1668
pubmed: 30788536
Support Care Cancer. 2021 Dec;29(12):7785-7791
pubmed: 34169328
World J Surg. 2019 Mar;43(3):659-695
pubmed: 30426190
Gastroenterology. 2018 Aug;155(2):391-410.e4
pubmed: 29750973
Dis Colon Rectum. 2017 Aug;60(8):761-784
pubmed: 28682962
Int J Sports Med. 2013 Jul;34(7):631-6
pubmed: 23444095
Eur J Surg Oncol. 2017 Nov;43(11):2084-2092
pubmed: 28943177
Stat Methods Med Res. 2018 Jun;27(6):1785-1805
pubmed: 27683581
Cancer Epidemiol Biomarkers Prev. 2016 Jun;25(6):969-77
pubmed: 27197271
BMC Sports Sci Med Rehabil. 2021 Feb 23;13(1):15
pubmed: 33622370
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Br J Anaesth. 2015 Feb;114(2):244-51
pubmed: 25274049
Anesthesiology. 2014 Nov;121(5):937-47
pubmed: 25076007
Ann Surg. 2022 Mar 1;275(3):448-455
pubmed: 33843798
Ann Oncol. 2015 Feb;26(2):272-8
pubmed: 25009011
Arch Phys Med Rehabil. 2008 Jun;89(6):1083-9
pubmed: 18503803
J Gastrointest Surg. 2020 Dec;24(12):2829-2837
pubmed: 31768827
PLoS One. 2019 Jul 2;14(7):e0219158
pubmed: 31265476
Clin Endocrinol (Oxf). 2018 Nov;89(5):554-567
pubmed: 30047158
Br J Surg. 2010 Aug;97(8):1187-97
pubmed: 20602503
Dtsch Arztebl Int. 2019 Nov 1;116(44):739-746
pubmed: 31774053
Am J Phys Med Rehabil. 2019 Oct;98(10):888-896
pubmed: 31090551
Eur J Surg Oncol. 2016 Jan;42(1):28-38
pubmed: 26506862
J Thorac Oncol. 2007 Jul;2(7):619-25
pubmed: 17607117
Eur J Surg Oncol. 2019 Dec;45(12):2295-2301
pubmed: 31362842
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
Int J Cancer. 2019 Jun 15;144(12):2992-3000
pubmed: 30536395
Anaesthesia. 2013 Aug;68(8):811-6
pubmed: 23789780
Trials. 2021 Jan 6;22(1):26
pubmed: 33407782
Cir Esp (Engl Ed). 2020 Dec;98(10):605-611
pubmed: 32430159
Anaesthesia. 2018 Jun;73(6):750-768
pubmed: 29330843
Surgery. 2016 Nov;160(5):1189-1201
pubmed: 27397681
Ann Surg. 2021 Jul 1;274(1):70-77
pubmed: 33201129
Front Surg. 2021 Mar 19;8:628848
pubmed: 33816546
J Gastrointest Surg. 2020 Jun;24(6):1375-1385
pubmed: 31228083
BJS Open. 2020 Sep 22;:
pubmed: 32959532
Pilot Feasibility Stud. 2022 Jan 21;8(1):11
pubmed: 35063042
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
World J Surg. 2017 Apr;41(4):899-913
pubmed: 27822725
Br J Anaesth. 2016 Feb;116(2):177-91
pubmed: 26787788
Eur J Surg Oncol. 2019 Apr;45(4):510-518
pubmed: 30910052
Int J Qual Health Care. 2013 Apr;25(2):197-204
pubmed: 23349426
Surgery. 2017 Feb;161(2):525-532
pubmed: 27687623
Colorectal Dis. 2016 Aug;18(8):O267-77
pubmed: 27332897
PLoS One. 2019 Jun 13;14(6):e0218152
pubmed: 31194798
Clin Rehabil. 2010 Jul;24(7):614-22
pubmed: 20530651
CA Cancer J Clin. 2020 May;70(3):145-164
pubmed: 32133645
Anaesthesia. 2021 Jan;76(1):82-90
pubmed: 32761611
JAMA Surg. 2020 Mar 1;155(3):233-242
pubmed: 31968063
Support Care Cancer. 2020 Jul;28(7):3197-3206
pubmed: 31712950
Perioper Med (Lond). 2017 Feb 16;6:3
pubmed: 28228938
Crit Care. 2004 Oct;8(5):369-72
pubmed: 15469600
Chron Respir Dis. 2015 May;12(2):146-54
pubmed: 25749346
Ann Surg. 2011 Dec;254(6):907-13
pubmed: 21562405
Surg Endosc. 2022 Feb;36(2):1008-1017
pubmed: 33723969

Auteurs

Roberto Falz (R)

Institute of Sport Medicine and Prevention, University Leipzig, Rosa-Luxemburg-Str. 20-30, 04103, Leipzig, Germany. Roberto.falz@uni-leipzig.de.

Christian Bischoff (C)

Institute of Sport Medicine and Prevention, University Leipzig, Rosa-Luxemburg-Str. 20-30, 04103, Leipzig, Germany.

René Thieme (R)

Department of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital Leipzig, Leipzig, Germany.

Johannes Lässing (J)

Institute of Sport Medicine and Prevention, University Leipzig, Rosa-Luxemburg-Str. 20-30, 04103, Leipzig, Germany.

Matthias Mehdorn (M)

Department of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital Leipzig, Leipzig, Germany.

Sigmar Stelzner (S)

Department of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital Leipzig, Leipzig, Germany.

Martin Busse (M)

Institute of Sport Medicine and Prevention, University Leipzig, Rosa-Luxemburg-Str. 20-30, 04103, Leipzig, Germany.

Ines Gockel (I)

Department of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital Leipzig, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH